Ipigrix (Ipidacrine Hydrochloride)

Ipidacrine Hydrochloride reversibly blocks acetylcholinesterase, the enzyme that degrades acetylcholine. This inhibition raises acetylcholine levels in synapses, enhancing cholinergic signaling that supports learning and memory.

The appropriate dose of Ipigrix is determined by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and response to therapy. No fixed regimen is provided here.

Safety data for Ipigrix in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and under medical supervision.

To place an order, submit an enquiry on the Ipigrix product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Ipigrix belongs to the reversible acetylcholinesterase inhibitor class, similar to drugs like donepezil and rivastigmine. Compared with irreversible inhibitors, Ipigrix may offer a different safety profile, but clinical choice depends on individual patient response and tolerability.

Ipigrix tablets should be stored at ambient temperature, below 25 °C, in the original container, protected from moisture, heat and direct sunlight to maintain stability.

Ipigrix is taken orally, usually with water. The exact timing (with or without food) and frequency are directed by the prescribing healthcare professional.

Serious risks include hepatotoxicity, severe allergic reactions such as anaphylaxis, cardiac arrhythmias, seizures, profound hypotension and psychotic episodes. Patients should be monitored for these events, especially during treatment initiation.

Ipigrix is contraindicated in patients with known hypersensitivity to Ipidacrine Hydrochloride, those taking other acetylcholinesterase inhibitors, and individuals with severe hepatic or renal impairment unless closely supervised by a physician.